Skip to content
1st Counsel – Lifestyle
Author:
SCALED AGILE
Boehringer Ingelheim’s oncology portfolio shows strong promise across multiple cancers at ASCO 2026
May 22, 2026
Beamion LUNG-1 study results for zongertinib in treatment-naïve patients with HER2-mutant advanced NSCLC published in The New England of Journal of Medicine
April 17, 2026
/C O R R E C T I O N — Boehringer Ingelheim/
April 16, 2026
Thirty Times More Companies Cut Headcount Because They Are Anticipating AI Value Versus Realizing Actual Value
March 17, 2026
Scaled Agile to Host Annual SAFe® & AI Summit to Help Bridge the Path from Agile Excellence to AI-Native
March 5, 2026